Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression

NCT01309945 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

889

Enrollment

INDUSTRY

Sponsor class

Conditions

Depression

Interventions

DRUG: Duloxetine
DRUG: Placebo matching with BMS-820836
DRUG: BMS-820836
DRUG: Duloxetine
DRUG: Placebo matching with Duloxetine

Sponsor

Bristol-Myers Squibb